Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Declines By 28.4%

Applied DNA Sciences, Inc. (NASDAQ:APDNGet Free Report) was the recipient of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 611,100 shares, a drop of 28.4% from the October 15th total of 853,200 shares. Based on an average trading volume of 11,550,000 shares, the days-to-cover ratio is presently 0.1 days.

Applied DNA Sciences Stock Down 6.8 %

APDN traded down $0.01 during trading on Friday, reaching $0.16. The stock had a trading volume of 2,759,494 shares, compared to its average volume of 3,764,022. Applied DNA Sciences has a 1-year low of $0.15 and a 1-year high of $22.80. The firm has a market capitalization of $5.06 million, a price-to-earnings ratio of -0.01 and a beta of 0.46. The stock has a 50 day moving average of $0.60 and a two-hundred day moving average of $1.03.

Hedge Funds Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Jane Street Group LLC purchased a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDNFree Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned 0.24% of Applied DNA Sciences at the end of the most recent reporting period. 22.22% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Applied DNA Sciences to a “sell” rating in a research note on Tuesday, September 17th.

View Our Latest Stock Report on Applied DNA Sciences

Applied DNA Sciences Company Profile

(Get Free Report)

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.

Recommended Stories

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.